GTM for Genomics Chrysalis client base includes startups and investors in healthcare and life sciences tools, creating demand for end-to-end go-to-market and product commercialization support. An opportunity exists to offer a tailored GTM program for genomics driven tools, including market segmentation, messaging, channel strategy, and pilot initiatives to accelerate early revenue.

Investor Portfolio Support Investors who work with Chrysalis can use portfolio acceleration services to help their companies scale faster. Offer due diligence support, market landscape assessments, and growth roadmaps to reduce investment risk and speed value realization.

Diagnostics Market Access Molecular diagnostics startups face regulatory, clinical evidence, and reimbursement hurdles. Provide regulatory strategy, clinical validation planning, and payer strategy to shorten time to market and improve payer adoption.

Competitive Benchmarking Clients require ongoing market intelligence to stay ahead of incumbents. Offer ongoing competitive benchmarking, market trend reports, and scenario planning as a value service.

Fractional Leadership Chrysalis emphasizes hands on involvement of principals. There is a market for fractional chief commercial officer and program management support to drive multi month engagements without full-time hires.